GSK plcis pushing for policy changes that would make it easier for US seniors to get its new respiratory syncytial virus (RSV) at their physician’s offices ahead of the Centers for Disease Control and Prevention’s review of the vaccine later this month.
Key Takeaways
-
Adult vaccination schedule is getting more complicated and crowded which, could impact uptake of some or all vaccines as US still struggles to return to pre-COVID vaccination rates.
The payment reform request is just one of a handful of efforts GSK is working on as part of its...